# Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

> **NCT04721873** · PHASE2 · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 40 (estimated)

## Conditions studied

- Colitis, Ulcerative
- Obesity

## Interventions

- **DRUG:** Phentermine-Topiramate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04721873
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-18
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04721873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04721873, "Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04721873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*